MedTrace Logo

Reduction of Sitting Time: Sedentarism Intervention Trial

NCT01221363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2015-01-21

Study results available
· View outcomes & findings →

Summary

Recent studies have suggested that prolonged daily sitting time may in itself have a negative effect on health, even in people who engage in daily physical activity.

The aim of the present study is to explore whether individually tailored lifestyle counselling aimed at reducing TV-viewing and other sedentary activities during leisure time and at work, can reduce sitting time and waist circumference, weight and blood pressure; and improve serum lipid levels. From a population-based health survey, 150 adult men and women with more than 3.5 hours of daily leisure time sitting time are recruited and randomly assigned to 1) an intervention group or 2) a control group. The intervention group will participate in 4 individually tailored lifestyle intervention sessions focussing on reduction of daily sitting time. The control group will receive no intervention.

Conditions

  • Life Style
  • Physical Activity
  • Sedentary Behavior

Interventions

BEHAVIORAL

Life style intervention

Reduction of sedentary behavior through theory-based individually tailored lifestyle intervention.

Sponsors & Collaborators

  • Lundbeck Foundation

    collaborator OTHER

  • Sygekassernes Helsefond

    collaborator OTHER

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Torben Jørgensen, Prof. DrMedSc · Research Centre for Prevention and Health, the Capital Region of Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-03-31
Completion
2012-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221363 on ClinicalTrials.gov